CLZ-3001

N/A

Report date: 2023/08/04 13:44:09

Base Information

Drug NameCLZ-3001
Drug Alias NameNK cell Therapy(Cellatoz Therapeutics)CLZ-3001
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cell replacements
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellatoz Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellatoz Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungOvarian NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A